Table:
begin	end	state
1	17	cytoplasmic
18	38	transmembrane
39	53	non-cytoplasmic
54	75	transmembrane
76	95	cytoplasmic
96	119	transmembrane
120	130	non-cytoplasmic
131	152	transmembrane
153	156	cytoplasmic
157	174	transmembrane
175	178	non-cytoplasmic
179	203	transmembrane
204	209	cytoplasmic
210	231	transmembrane
232	244	non-cytoplasmic
245	265	transmembrane
266	272	cytoplasmic
273	291	transmembrane
292	324	non-cytoplasmic
325	344	transmembrane
345	361	cytoplasmic
362	388	transmembrane
389	407	non-cytoplasmic
408	425	transmembrane
426	456	cytoplasmic

Input:
>WP_012591091.1 NCBI__GCF_000021745.1:WP_012591091.1
MQSSLTPARSRSRLKDALTGAAIAGAIMFGLCFPILAFRTDQNFSNELYLLSRWPAVAFA
VGAVFVLRFAMLMLPPREPRPQAPPSPARAGALQRLARYAGAVGILALIAFPLVMVALLG
PAGAQKWIDNFGVQILLYVLLGWGLNIVVGLAGLLDLGYVAFYAVGAYAYALLATHFGWS
FWLCLPVAGLLAAGFGVALGLPVLRLRGDYLAIVTMAFGEIIRLVLTNWTALTNGDAGIS
SIPRITFFGWPFIAGPNGFAALFGLKFAPVHRLIFLFYLILALALCVNYLTRRLRKAPLG
RAFEALREDEIACRSLGVDTVATKLTAFALGASIAGMAGALFAARQNFVSPTSFTFMESA
TILALVVLGGAGSQLGVALAAIVIIGGSEILRELDGLKQIFGPAFDPTQYRMLIVGIAMV
GMMNWRPRGLIALRTPSIFLKKPKLVVGALAGEGRG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server